Sodium iodide symporter

Its biology, clinical relevance, and potential role in the pathophysiology of autoimmune thyroid disease

C. Spitzweg, E. R. Bergert, J. C. Morris

Research output: Contribution to journalReview article

Abstract

As the thyroidal membrane protein that mediates iodide transport into thyroidal follicular cells, sodium iodide symporter plays a key role in thyroid pathophysiology and allows effective use of radioiodine for diagnosis and therapy of thyroid cancer. Because of the critical role sodium iodide symporter plays in thyroid function, its potential role as a novel thyroid autoantigen in the pathogenesis of autoimmune thyroid disease has become the focus of many studies. Recent reports involving large series of patient samples and specific and quantitative binding assays were unable to confirm early, promising data that suggested a pathogenic role of sodium iodide symporter in autoimmune thyroid disease. On the other hand, although further studies are needed to determine the clinical importance of sodium iodide symporter as a thyroidal autoantigen, sodium iodide symporter expression detected in mammary glands may have important diagnostic and therapeutic implications in breast cancer. One of the most exciting and promising chapters of sodium iodide symporter gene-based research since its cloning in 1996 is the characterization and application of sodium iodide symporter as a novel therapeutic gene for cytoreductive gene therapy based on targeted sodium iodide symporter gene transfer followed by radioiodine therapy for nonthyroid malignancies. Curt Opin

Original languageEnglish (US)
Pages (from-to)259-265
Number of pages7
JournalCurrent Opinion in Endocrinology and Diabetes
Volume8
Issue number5
DOIs
StatePublished - 2001

Fingerprint

Thyroid Diseases
Autoimmune Diseases
Thyroid Gland
Autoantigens
Genes
sodium-iodide symporter
Iodides
Therapeutics
Human Mammary Glands
Thyroid Neoplasms
Genetic Therapy
Organism Cloning
Membrane Proteins
Breast Neoplasms
Research

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Sodium iodide symporter : Its biology, clinical relevance, and potential role in the pathophysiology of autoimmune thyroid disease. / Spitzweg, C.; Bergert, E. R.; Morris, J. C.

In: Current Opinion in Endocrinology and Diabetes, Vol. 8, No. 5, 2001, p. 259-265.

Research output: Contribution to journalReview article

@article{83781b2c1db54ad09a65b8ae05a77462,
title = "Sodium iodide symporter: Its biology, clinical relevance, and potential role in the pathophysiology of autoimmune thyroid disease",
abstract = "As the thyroidal membrane protein that mediates iodide transport into thyroidal follicular cells, sodium iodide symporter plays a key role in thyroid pathophysiology and allows effective use of radioiodine for diagnosis and therapy of thyroid cancer. Because of the critical role sodium iodide symporter plays in thyroid function, its potential role as a novel thyroid autoantigen in the pathogenesis of autoimmune thyroid disease has become the focus of many studies. Recent reports involving large series of patient samples and specific and quantitative binding assays were unable to confirm early, promising data that suggested a pathogenic role of sodium iodide symporter in autoimmune thyroid disease. On the other hand, although further studies are needed to determine the clinical importance of sodium iodide symporter as a thyroidal autoantigen, sodium iodide symporter expression detected in mammary glands may have important diagnostic and therapeutic implications in breast cancer. One of the most exciting and promising chapters of sodium iodide symporter gene-based research since its cloning in 1996 is the characterization and application of sodium iodide symporter as a novel therapeutic gene for cytoreductive gene therapy based on targeted sodium iodide symporter gene transfer followed by radioiodine therapy for nonthyroid malignancies. Curt Opin",
author = "C. Spitzweg and Bergert, {E. R.} and Morris, {J. C.}",
year = "2001",
doi = "10.1097/00060793-200110000-00006",
language = "English (US)",
volume = "8",
pages = "259--265",
journal = "Current Opinion in Endocrinology, Diabetes and Obesity",
issn = "1752-296X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Sodium iodide symporter

T2 - Its biology, clinical relevance, and potential role in the pathophysiology of autoimmune thyroid disease

AU - Spitzweg, C.

AU - Bergert, E. R.

AU - Morris, J. C.

PY - 2001

Y1 - 2001

N2 - As the thyroidal membrane protein that mediates iodide transport into thyroidal follicular cells, sodium iodide symporter plays a key role in thyroid pathophysiology and allows effective use of radioiodine for diagnosis and therapy of thyroid cancer. Because of the critical role sodium iodide symporter plays in thyroid function, its potential role as a novel thyroid autoantigen in the pathogenesis of autoimmune thyroid disease has become the focus of many studies. Recent reports involving large series of patient samples and specific and quantitative binding assays were unable to confirm early, promising data that suggested a pathogenic role of sodium iodide symporter in autoimmune thyroid disease. On the other hand, although further studies are needed to determine the clinical importance of sodium iodide symporter as a thyroidal autoantigen, sodium iodide symporter expression detected in mammary glands may have important diagnostic and therapeutic implications in breast cancer. One of the most exciting and promising chapters of sodium iodide symporter gene-based research since its cloning in 1996 is the characterization and application of sodium iodide symporter as a novel therapeutic gene for cytoreductive gene therapy based on targeted sodium iodide symporter gene transfer followed by radioiodine therapy for nonthyroid malignancies. Curt Opin

AB - As the thyroidal membrane protein that mediates iodide transport into thyroidal follicular cells, sodium iodide symporter plays a key role in thyroid pathophysiology and allows effective use of radioiodine for diagnosis and therapy of thyroid cancer. Because of the critical role sodium iodide symporter plays in thyroid function, its potential role as a novel thyroid autoantigen in the pathogenesis of autoimmune thyroid disease has become the focus of many studies. Recent reports involving large series of patient samples and specific and quantitative binding assays were unable to confirm early, promising data that suggested a pathogenic role of sodium iodide symporter in autoimmune thyroid disease. On the other hand, although further studies are needed to determine the clinical importance of sodium iodide symporter as a thyroidal autoantigen, sodium iodide symporter expression detected in mammary glands may have important diagnostic and therapeutic implications in breast cancer. One of the most exciting and promising chapters of sodium iodide symporter gene-based research since its cloning in 1996 is the characterization and application of sodium iodide symporter as a novel therapeutic gene for cytoreductive gene therapy based on targeted sodium iodide symporter gene transfer followed by radioiodine therapy for nonthyroid malignancies. Curt Opin

UR - http://www.scopus.com/inward/record.url?scp=0034803427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034803427&partnerID=8YFLogxK

U2 - 10.1097/00060793-200110000-00006

DO - 10.1097/00060793-200110000-00006

M3 - Review article

VL - 8

SP - 259

EP - 265

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

SN - 1752-296X

IS - 5

ER -